COMPANY OVERVIEW

Aprea Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53.

---

LOCATION

Boston, MA, USA

Solna, , Sweden

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.aprea.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Aug 5, 2019

Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer

Apr 16, 2019

Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)

Mar 25, 2019

Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer

Feb 27, 2019

Aprea Therapeutics Adds New Investor to Series C Financing

Jan 7, 2019

Aprea Therapeutics Announces Presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco

For More Press Releases

---